Autonomous Research for Accelerated Discovery

Obelisk is building autonomous AI scientists trained on curated biomedical data to accelerate pharmaceutical discovery.

 

By combining academic-style agent training with reproducible in silico experimentation, we generate novel, testable insights that reduce the time and cost of drug development.